Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

Showing 20 of 0 results

Not applicableStudy completedNCT01536626
What this trial is testing

Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 211
Early research (Phase 1)Study completedNCT01173926
What this trial is testing

Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 27
Not applicableStudy completedNCT00737776
What this trial is testing

Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,068
Large-scale testing (Phase 3)Study completedNCT03770767
What this trial is testing

Insulin Fiasp vs. Insulin Novorapid During Pregnancy and Laction in Women With Pre-existing Diabetes

Who this might be right for
Diabetes MellitusPregnancy Complications
Rigshospitalet, Denmark 216
Testing effectiveness (Phase 2)Study completedNCT03816761
What this trial is testing

Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Novo Nordisk A/S 24
Early research (Phase 1)Study completedNCT01242826
What this trial is testing

Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 24
Large-scale testing (Phase 3)Study completedNCT01850615
What this trial is testing

Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 323
Large-scale testing (Phase 3)Study completedNCT01999322
What this trial is testing

A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 37
Large-scale testing (Phase 3)Study completedNCT00474045
What this trial is testing

Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 470
Large-scale testing (Phase 3)Study completedNCT02762578
What this trial is testing

Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 543
Post-approval studies (Phase 4)Study completedNCT02467920
What this trial is testing

Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM

Who this might be right for
Type 2 Diabetes Mellitus
Huazhong University of Science and Technology 349
Testing effectiveness (Phase 2)Study completedNCT00353990
What this trial is testing

Bioavailability of Insulin Administered in Duodenum

Who this might be right for
Diabetes Mellitus
University of Aarhus 12
Post-approval studies (Phase 4)Study completedNCT01212913
What this trial is testing

Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 161
Not applicableStudy completedNCT03745157
What this trial is testing

RESILIENT: A Research Study, Looking at How Ryzodeg® Works in People With Type 2 Diabetes in Local Clinical Practice in Japan

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 246
Large-scale testing (Phase 3)Study completedNCT01467375
What this trial is testing

Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 89
Not applicableStudy completedNCT01565733
What this trial is testing

Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 2,223
Large-scale testing (Phase 3)Study completedNCT00612599
What this trial is testing

Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 75
Early research (Phase 1)Study completedNCT01486914
What this trial is testing

Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 28
Post-approval studies (Phase 4)Study completedNCT00117780
What this trial is testing

Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 520
Post-approval studies (Phase 4)Study completedNCT00497536
What this trial is testing

Pharmacokinetics of IAsp Following CSII in Patients With T1DM

Who this might be right for
Type 1 Diabetes Mellitus
University of Aarhus 12
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation